Despite the implementation of a new blanket scheduling system in 2013, new psychoactive substance (NPS) abuse remains a serious social concern in Japan. We present a fatal intoxication case involving 5F-ADB (methyl 2-[1-(5-fluoropentyl)-1H-indazole-3-carboxamido]-3,3-dimethylbutanoate) and diphenidine. Postmortem blood screening by liquid chromatography/quadrupole time-of-flight mass spectrometry (LC/Q-TOFMS) in the information-dependent acquisition mode only detected diphenidine. Further urinary screening using an in-house database containing NPS and metabolites detected not only diphenidine but also possible 5F-ADB metabolites; subsequent targeted screening by LC/tandem mass spectrometry (LC/MS/MS) allowed for the detection of a very low level of unchanged 5F-ADB in postmortem heart blood. Quantification by standard addition resulted in the postmortem blood concentrations being 0.19 ± 0.04 ng/mL for 5F-ADB and 12 ± 2.6 ng/mL for diphenidine. Investigation of the urinary metabolites revealed pathways involving ester hydrolysis (M1) and oxidative defluorination (M2), and further oxidation to the carboxylic acid (M3) for 5F-ADB. Mono- and di-hydroxylated diphenidine metabolites were also found. The present case demonstrates the importance of urinary metabolite screening for drugs with low blood concentration. Synthetic cannabinoids (SCs) fluorinated at the terminal N-alkyl position are known to show higher cannabinoid receptor affinity relative to their non-fluorinated analogues; 5F-ADB is no exception with high CB receptor activity and much greater potency than Δ -THC and other earlier SCs, thus we suspect its acute toxicity to be high compared to other structurally related SC analogues. The low blood concentration of 5F-ADB may be attributed to enzymatic and/or non-enzymatic degradation, and further investigation into these possibilities is underway.

: Previous work has demonstrated the ability to differentiate individuals based on the analysis of human scent hand odor chemicals. In this paper, a range of forensic biological specimens are shown to also have the ability to differentiate individuals based upon the volatile organic compounds (VOCs) present. Human VOC profiles from hand odor, oral fluid, breath, blood, and urine of 31 individuals were analyzed by solid‐phase microextraction–gas chromatography–mass spectrometry (SPME‐GC‐MS) and combined methods of chromatogram comparison, Spearman rank correlation comparison, and principal component analysis. Intra‐specimen comparisons demonstrated the distinguishability of individuals above 99%. Inter‐specimen VOC profiles from the same individual were found to be too different to be used for scent‐matching purposes, with Spearman rank coefficients below 0.15. A 6‐month VOC profile monitoring of two individuals demonstrated the consistency of VOC profiles over time across specimens.

No abstract

In recent years, interest has increased regarding the identification of volatile organic compounds (VOCs) for metabolic profiling, human scent identification of the living and deceased, and diagnostic potentials for certain diseases that are known for its association with distinct odor. In this study, a method has been developed that is capable of sampling, identifying, and differentiating the VOCs present in various biological specimens of forensic importance (blood, breath, buccal cells, and urine) taken from the same individuals. The developed method requires a pretreatment step to remove targeted VOCs from the sampling apparatus prior to sampling of the individual specimens. The VOCs collected from the biological specimens were characterized by solid-phase microextraction and gas chromatography/mass spectrometry with ratios of the most abundant and frequent VOCs compared using qualitative and semiquantitative methods. Blood, breath, and buccal cells required extraction procedures ranging from 18 to 21 h in order to optimize the limit of detection, which averaged 5-15 ng across these specimens. The optimal method for measuring urine VOCs was complete in less than an hour; however, the limit of detection was higher with a range of 10-40 ng quantifiable. The demonstrated sensitivity and reproducibility of the methods developed allow for population studies of human scent VOCs from various biological specimen collection kits used in the forensic and clinical fields.